PyrAmes Raises $6 Million in Series A Financing
CUPERTINO, Calif., April 20, 2021 -- (Healthcare Sales & Marketing Network) -- PyrAmes, Inc., a digital healthcare company focused on innovative products for continuous blood pressure monitoring, today announced the completion of a $6 million Series A fin... Devices, Monitoring, Cardiology, Venture Capital PyrAmes, Boppli, blood pressure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2021 Category: Pharmaceuticals Source Type: news

Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
SHEFFIELD, England, April 20, 2021 -- (Healthcare Sales & Marketing Network) -- Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from exist... Regenerative Medicine, Venture Capital Rinri Therapeutics, stem cell, sensorineural hearing loss (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2021 Category: Pharmaceuticals Source Type: news

Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Funding to Support Validation Testing of the First Tankless Inhaled Nitric Oxide (iNO) Wearable Device for Home Use WALTHAM, Mass., April 15, 2021 -- (Healthcare Sales & Marketing Network) -- Third Pole Therapeutics, a privately held company developing... Devices, Venture Capital Third Pole Therapeutics, inhaled nitric oxide, tankless iNO (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2021 Category: Pharmaceuticals Source Type: news

‘One Billion Doses On Day One’: Vaccine Company Claims World-Changing Innovation
It ’s hard to flawlessly churn out billions of doses of drugs—and we aren’t doing a great job of it. A Midas List VC pulled together a dream team that says it’s come up with a better, faster way. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 15, 2021 Category: Pharmaceuticals Authors: Amy Feldman, Forbes Staff Tags: Manufacturing /manufacturing Business /business Innovation /innovation Venture Capital /venture-capital Healthcare /healthcare Entrepreneurs /entrepreneurs Editors' Pick editors-pick Daily Cover daily-cover Source Type: news

This Startup Raised $25 Million To Liberate Your Healthcare Data In The Cloud
1upHealth is helping health systems and insurers comply with new federal data sharing rules by standardizing and storing medical and claims information. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 14, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech Venture Capital /venture-capital Cloud /cloud Editors' Pick editors-pick Source Type: news

Biotech R & D Startup Benchling Hits $4 Billion Valuation As The Company Starts Laying Groundwork For An IPO
Sajith Wickramasekara was just 24 when he made the Forbes 30 Under 30 list for his biotech R&D startup, Benchling. Now his company is worth $4 billion with a new $200 million round led by Sequoia. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 14, 2021 Category: Pharmaceuticals Authors: Amy Feldman, Forbes Staff Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Leadership /leadership Under 30 /under30 Enterprise Tech /enterprise-tech Editors' Pick editor Source Type: news

Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Founded by pioneers of targeted oncology, Theseus is developing best-in-class TKIs to overcome cancer resistance Presentation at AACR highlights THE-630, the Company's next-generation inhibitor for KIT-mutant gastrointestinal stromal tumors (GIST) BO... Biopharmaceuticals, Oncology, Venture Capital Theseus Pharmaceuticals, targeted oncology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2021 Category: Pharmaceuticals Source Type: news

UMass Amherst joins partnership to develop sustainable food products
(University of Massachusetts Amherst) The University of Massachusetts Amherst is among nine institutions chosen to collaborate with Big Idea Ventures to help develop and commercialize new, sustainable food products and agricultural innovation that will fuel economic development in rural communities, the New York City-based venture capital firm announced Tuesday. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2021 Category: International Medicine & Public Health Source Type: news

Ginkgo Bioworks reportedly explores $20B SPAC deal
Synthetic biology company Ginkgo Bioworks is toying with the idea of going public via a reverse merger with special-purpose acquisition company Soaring Eagle Acquisition Corp. The potential deal, first reported by Bloomberg, could value Ginkgo at more than $20 billion — more than five times what Ginkgo was valued at in late 2019, when it last raised venture capital. Ginkgo Bioworks declined to comment. The news comes as deals with special-purpose acquisition compani es, known as the number of… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 12, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Memic Innovative Surgery Raises $96 Million
Financing led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed Funding primarily supports commercialization of Hominis® surgical robot in the United States following FDA De Novo marketing authorization TEL AVIV, Israe... Devices, Surgery, Venture Capital Memic Innovative Surgery, Hominis, robotic surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2021 Category: Pharmaceuticals Source Type: news

This Startup Raised $40 Million To Build A ‘Mini-Kaiser Permanente’ And Lower Employee Healthcare Costs
Firefly Health is aiming to get small business owners, who are being crushed by rising employee healthcare costs, to switch to its plan. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 7, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Editors' Pick editors-pick Source Type: news

Nearly 50% Of Venture-Backed Healthcare Companies Have No Women On The Board, New Report Shows
Women make most healthcare decisions but hold only 13% of board seats at venture-backed healthcare companies. Failure to increase diversity comes at a cost. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 6, 2021 Category: Pharmaceuticals Authors: Deb Gordon, Contributor Tags: Healthcare /healthcare Innovation /innovation Leadership /leadership ForbesWomen /forbeswomen Venture Capital /venture-capital Editors' Pick editors-pick Source Type: news

Mineralys Therapeutics Closes $40 Million Series A Funding
Financing Co-led by HBM Healthcare Investments and Samsara BioCapital Food and Drug Administration Accepts Investigational New Drug Application for MLS-101 and Advances to Phase 2 Proof-of-Concept Clinical Trial Company Announces Jon Congleton as Chi... Biopharmaceuticals, Cardiology, Venture Capital, Personnel Mineralys Therapeutics, aldosterone synthase, hypertension (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2021 Category: Pharmaceuticals Source Type: news

Main Line biotech firm raises $40M in Series A round to advance new high blood pressure treatment
Mineralys Therapeutics, a Radnor-based biopharmaceutical startup, said Tuesday it has raised $40 million through a private stock sale. Founded in 2020 by Tokyo venture capital firm Catalys Pacific, Mineralys is focused on developing new treatments for high blood pressure — also known as hypertension. The company's Series A funding round was led by HBM Healthcare Investments of Switzerland and Samsara BioCapital of Palo Alto, C alifornia. Catalys Pacific and Adam Street Partners also participated… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 6, 2021 Category: American Health Authors: John George Source Type: news

New Report Finds Digital Health Startups Raised Over $6.7 Billion In The First Quarter Of 2021
The Covid-19 pandemic fueled mega rounds as investors look to scale adoption of new technology. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 5, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Editors' Pick editors-pick Source Type: news

S4 Medical Closes Series A Financing
CLEVELAND, April 2, 2021 -- (Healthcare Sales & Marketing Network) -- S4 Medical moves a step closer in developing the most comprehensive solution to protect the esophagus from thermal injury during catheter ablation procedures for atrial fibrillation (AF... Devices, Venture Capital S4 Medical, esolution catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2021 Category: Pharmaceuticals Source Type: news

General Catalyst Doubles Down On Healthcare With $600 Million New Fund
The venture capital firm's first vertical-specific fund will invest in early- and growth-stage health startups, with hospital systems along for the ride. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 1, 2021 Category: Pharmaceuticals Authors: Alex Konrad, Forbes Staff Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick technology Source Type: news

These Stanford AI Lab Dropouts Raised $50 Million To Improve Conversations
Startup Cresta ’s Series B from Sequoia, Andreessen Horowitz, Greylock and others comes as the software maker for retail reps and call center agents quadrupled sales in 2020. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 31, 2021 Category: Pharmaceuticals Authors: Aayushi Pratap, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation AI /ai Cloud /cloud Venture Capital /venture-capital Enterprise Tech /enterprise-tech Editors' Pick editors-pick Source Type: news

Telehealth startup raises $25M to expand platform
The Series B funding round was led by Lux Capital, with other participants including actor Ashton Kutcher and a venture capital firm he co-founded, Sound Ventures. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 30, 2021 Category: American Health Authors: Diana Barr Source Type: news

Telehealth startup raises $25M to expand platform
The Series B funding round was led by Lux Capital, with other participants including actor Ashton Kutcher and a venture capital firm he co-founded, Sound Ventures. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 30, 2021 Category: Biotechnology Authors: Diana Barr Source Type: news

St. Louis telehealth startup SteadyMD raises $25M to expand platform
The Series B funding round was led by Lux Capital, with other participants including actor Ashton Kutcher and a venture capital firm he co-founded, Sound Ventures. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 30, 2021 Category: Health Management Authors: Diana Barr Source Type: news

Oncology startup to double size with $152M
With a freshly inked deal with Pfizer and an additional $152 million in its pocket, Cambridge, Massachusetts startup Pyxis Oncology is prepared to get its drugs into the clinic. Founded in 2019 by life sciences venture capital firm the Longwood Fund, Pyxis has three drug candidates in the works, all of which are antibody-drug compounds designed to target various forms of cancer. Two of the candidates, PYX-201 and PYX-203, were in-licensed from Pfizer, and a third, PYX-202 , was in-licensed from South… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 30, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Digital Health ’s Latest Unicorn Aims To Lower Employee Drug Costs
Rightway raised $100 million at a valuation of $1.1 billion for its navigation platform combined with a next generation pharmacy benefits manager. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 30, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Editors' Pick editors-pick Source Type: news

Four Questions Telehealth Companies Must Answer To Ensure Long Term Growth
Because while consumers may prefer telehealth and access to virtual care for an increasing portion of their healthcare needs, it is still payers and policymakers who act as gatekeepers to designing access to healthcare services in the vast majority of cases. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2021 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Decision Maker Content decisionmaker Source Type: news

Cityblock Health Gets $192 Million Funding Boost To Turbocharge Care For Low-Income Patients
The digital health unicorn is taking on the Medicaid market and betting its community-based model can keep members healthier while lowering costs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Leadership /leadership Diversity, Equity & Inclusion /diversity-equity-inclusion Editors' Pick editors-pick Decision Maker Content decisionmaker Source Type: news

'Ultimately, we want the best ideas': Why two biotech entrepreneurs joined a VC firm
Peter Van Vlasselaer and Chris Chai helped lead their companies to big buyouts by Big Pharma players. Now they've joined venture capital firm SR One to shape the future of the next generation of biotech startups. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 26, 2021 Category: American Health Authors: Ron Leuty Source Type: news

'Ultimately, we want the best ideas': Why two biotech entrepreneurs joined a VC firm
Peter Van Vlasselaer and Chris Chai helped lead their companies to big buyouts by Big Pharma players. Now they've joined venture capital firm SR One to shape the future of the next generation of biotech startups. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 26, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Constipation treatment Vibrant raises $7.5 million led by Unorthodox Ventures
Sequoia Capital invests for fourth time as treatment continues third round of FDA trials YOKNEAM ILLIT, Israel, March 26, 2021 -- (Healthcare Sales & Marketing Network) -- Vibrant, a leading developer of gastrointestinal treatments, today announced the... Devices, Gastroenterology, Venture Capital Vibrant Ltd, vibrating capsule (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 26, 2021 Category: Pharmaceuticals Source Type: news

Lightpoint Medical Announces $8 Million in Funding to Support Commercial Launch of its Robotic Cancer Detection Probe
CHESHAM, England and CAMBRIDGE, Mass., March 25, 2021 -- (Healthcare Sales & Marketing Network) -- Lightpoint Medical, a medical device company developing miniaturized cancer detection tools for robot-assisted surgery, announced today that it has complete... Devices, Oncology, Venture Capital Lightpoint Medical, SENSEI , intra-operative cancer detection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 25, 2021 Category: Pharmaceuticals Source Type: news

New Surveys Suggest Strong Support For Telehealth, But Policymakers Have Questions
While consumers may value the convenience and access that telehealth affords, policymakers have recently been weighing the remaining uncertainties of telehealth, and what the nation can afford. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 24, 2021 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Emalex Biosciences Raises $35 Million in Series C Preferred Stock to Advance Tourette Syndrome and Stuttering Clinical Trials
Funding led by Paragon Biosciences, joined by Fidelity Management & Research Company LLC and Valor Equity Partners CHICAGO, March 23, 2021 -- (Healthcare Sales & Marketing Network) -- Emalex Biosciences, Inc. ("Emalex"), a biopharmaceutical c... Biopharmaceuticals, Venture Capital Emalex Biosciences, ecopipam (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 23, 2021 Category: Pharmaceuticals Source Type: news

Digital Health Startup Ro Raised $500 Million At $5 Billion Valuation
The cash pay company looks to offer a full stack primary care solution in lieu of traditional health insurance, including pharmacy distribution and in-home diagnostics. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Editors' Pick editors-pick Source Type: news

Gravie raises $28M in venture capital
The round was led by AXA Venture Partners, the venture capital arm of the French insurance company Axa. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 19, 2021 Category: Biotechnology Authors: Carrigan Miller Source Type: news

Federal Grand Jury Indicts uBiome Cofounders On Criminal Fraud Charges
On Thursday, a Federal grand jury indicted biotech startup uBiome ’s cofounders Jessica Richman and Michael Apte with multiple charges related to defrauding insurance companies and investors. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 19, 2021 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Editors' Pick editors-pick technology alexknappblog Source Type: news

SEC Charges Microbiome Startup uBiome ’s Cofounders With Defrauding Investors For $60 Million
Jessica Richman and Zachary Apte were charged Thursday for failing to disclose significant issues related to the company's insurance billing practices. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 18, 2021 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Science /science Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Editors' Pick editors-pick Decision Maker Content decisionmaker technology alexknappblog Source Type: news

Aktis Oncology Announces $72M Series A Financing To Advance Breakthrough Radiopharmaceuticals To Treat Solid Tumors
Company Founded by MPM Capital, with Financing Co-Led by MPM Capital, EcoR1 Capital and Vida Ventures Proprietary Technology Platform Harnesses the Power of Alpha Particles to Target Solid Tumors Company Led by Industry Veteran Matthew Roden, PhD, Pr... Biopharmaceuticals, Oncology, Venture Capital, Personnel Aktis Oncology, radiopharmaceuticals, alpha radiotherapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 18, 2021 Category: Pharmaceuticals Source Type: news

Health execs from Gilead, Livongo and Ancestry join VC firm
Three San Francisco women who led large health-focused organizations — ex-Gilead Sciences CFO Robin Washington, former Ancestry President and CEO Margo Georgiadis and Livongo Health's ex-president, Dr. Jennifer Schneider — are joining venture capital firm General Catalyst as "endurance partners-in-residence." In their roles, the trio will work with General Catal yst portfolio companies from startup to later stages, the VC said. General Catalyst, based in New York, has offices in Palo Alto and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 18, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

‘Concierge Medicine On Steroids’ Startup Raised $40 Million To Disrupt Employer-Sponsored Care
With Transcarent, Glen Tullman and General Catalyst ’s Hemant Taneja are applying the Livongo playbook to the employer-sponsored healthcare system. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 18, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Leadership /leadership Editors' Pick editors-pick Source Type: news

Livongo Duo ’s New Venture Takes Aim At Rising Employer Healthcare Costs
With Transcarent, Glen Tullman and General Catalyst ’s Hemant Taneja are applying the Livongo playbook to the employer-sponsored healthcare system. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 18, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Leadership /leadership Editors' Pick editors-pick Source Type: news

VLP Therapeutics raises $16M Series A for cancer treatment vaccine RandD
GAITHERSBURG, Md., March 15, 2021 -- (Healthcare Sales & Marketing Network) -- US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on March 15 that it has raised US$16 million in a Series A funding round from MIYAKO Capital Co., Ltd., Sojitz ... Biopharmaceuticals, Oncology, Venture Capital VLP Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2021 Category: Pharmaceuticals Source Type: news

TJ Mayes' new venture to focus on lack of SA biomed VC funding
Alamo City lawyer T.J. Mayes is launching a new firm to try to draw more biotech venture capital to the region. Mayes said a lack of significant funding needed to grow San Antonio’s biomedical industry could leave the city further behind competing markets, facing a tougher pitch to recruit and retain companies and talent. “We don't have sufficient venture capital dedicated to San Antonio, biomedical re search,” said Mayes, who recently launched T.J. Mayes PLLC after departing the law firm… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 10, 2021 Category: American Health Authors: W. Scott Bailey Source Type: news

That ’s Just The Way It Is? Why Home Health Complexities Make Case For Investment, Not Demonization
It's easy to spot problems and demonize home health agencies. But a broader view that takes into account the complexity of providing care at home paints a different picture. One that beds for investment, not vilification, (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 9, 2021 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Missionary Misfits: Meet Joe DeRisi, A Real-Life Virus Hunter
As we approach the one-year anniversary of when the coronavirus really started to impact our lives, I thought it might be interesting to chat with a real-life virus hunter. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 8, 2021 Category: Pharmaceuticals Authors: Steve Vassallo, Contributor Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Coronavirus Source Type: news

Century Therapeutics raises $160M to advance cell therapy development
The funding is one of the largest venture capital deals this year for a company in the region. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 3, 2021 Category: American Health Authors: John George Source Type: news

Medisafe Secures $30M in Series C Funding to Build Future Model of Patient Support
Investments led by Sanofi Ventures and ALIVE Israel HealthTech Fund The digital health leader readies for solution expansion across the healthcare ecosystem with latest round of funding BOSTON, Feb. 25, 2021 -- (Healthcare Sales & Marketing Network) ... Devices, Venture Capital Medisafe , digital therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 25, 2021 Category: Pharmaceuticals Source Type: news

Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
CAMBRIDGE, Mass., Feb. 25, 2021 -- (Healthcare Sales & Marketing Network) -- Cellarity, a life sciences company founded by Flagship Pioneering to develop a new method of drug discovery targeting the cell, announced today that it raised $123 million in Ser... Biopharmaceuticals, Venture Capital Cellarity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 25, 2021 Category: Pharmaceuticals Source Type: news

This Startup Raised $45 Million To Connect Healthcare Data In The Cloud
Redox, which is geared towards software developers and hospital systems, aims to do for healthcare what Plaid did for the financial services industry. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 24, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Cloud /cloud Enterprise Tech /enterprise-tech Venture Capital /venture-capital Editors' Pick editors-pick Source Type: news

Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Funding Will Accelerate FDA Submission and Commercialization of Automated Benchtop Blood Testing System TYH Ventures, Glen Tullman of 7WireVentures, and Wittington Ventures Led the Round, Joined by General Catalyst, GreatPoint Ventures, DNS Capital, and... Diagnostics, Venture Capital, Personnel Truvian Sciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 24, 2021 Category: Pharmaceuticals Source Type: news

Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies
Synthetic circular RNA (oRNA) combines nature-driven insights with rational design to produce a bold new class of RNA therapeutics Therapeutic potential across a broad range of diseases including cancer, autoimmune, and genetic disorders CAMBRIDGE, M... Biopharmaceuticals, Venture Capital Orna Therapeutics, circular RNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 24, 2021 Category: Pharmaceuticals Source Type: news

For UCLA-based startup, new muscular dystrophy treatment is a personal mission
Courtney Young helped develop the gene therapy at the heart of a biotech startup,MyoGene Bio, when she was a doctoral student at UCLA from 2013 to 2018. But the kernel of the company ’s endeavor is older still — and definitively personal.In 2008, when Young was in high school, she found out that her cousin, then just a toddler, had been diagnosed with Duchenne muscular dystrophy. She made it her mission to cultivate the skills needed to provide better options for him and others who were suffering with the deadly muscle-wasting disease.“I directed my career toward working on Duchenne,” said Young, My...
Source: UCLA Newsroom: Health Sciences - February 23, 2021 Category: Universities & Medical Training Source Type: news